Induction of circulating soluble tumour necrosis factor receptor and interleukin 1 receptor antagonist following interleukin 1α infusion in humans

Cytokine

Volumn 6, Issue 2, 1994, Pages 215-219

  Tilg, Herbert ^a   Trehu, Elizabeth ^a   Shapiro, Leland ^a   Pape, Dietrich ^a   Atkins, Michael B ^a   Dinarello, Charles A ^a   Mier, James W ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Cytokine antagonists; IL 1 receptor antagonist; IL 1 ; Immunotherapy; Soluble TNF receptor

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOKINE RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; TUMOR NECROSIS FACTOR;

ARTICLE; BLOOD LEVEL; CANCER; CANCER IMMUNOTHERAPY; CASE REPORT; DRUG THERAPY; HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

CYCLOPHOSPHAMIDE; HUMAN; INFUSIONS, INTRAVENOUS; INTERLEUKIN-1; KINETICS; NEOPLASMS; RECEPTORS, INTERLEUKIN-1; RECEPTORS, TUMOR NECROSIS FACTOR; SIALOGLYCOPROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0028021855     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/1043-4666(94)90044-2     Document Type: Article

References (28)

1. Interleukin-1 and interleukin-1 antagonism
2. The effects of treatment with interleukin-1α on platelet recovery after high-dose carboplatin
3. A human inhibitor of tumour necrosis factor α
4. Two tumour necrosis factor-binding proteins purified from human urine
5. Molecular cloning and expression of the human 55kD tumour necrosis factor receptor
6. Molecular cloning and expression of a receptor for human tumor necrosis factor
7. Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivate, tumor necrosis factor-binding protein
8. Soluble forms of tumor necrosis factor receptors (TNF-Rs)
9. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins
10. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor
11. Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor
12. A urine inhibitor of interleukin-1 activity that blocks ligand binding
13. Effect of IL-1ra on IL-1 signal transduction
14. Interleukin-1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica
15. Coordinated anti-inflammatory effects of interleukin-4: Interleukin-4 suppresses interleukin-1 production but up-regulates gene expression and synthesis of interleukin-1 receptor antagonist
16. Phase I evaluation of thrice daily intravenous bolus interleukin-4 (IL-4) in patients with refractory malignancies
17. Induction of circulating IL-1 receptor antagonist by interferon treatment
18. Production of interleukin-1 receptor antagonist and interleukin-1β by peripheral blood mononuclear cells is differentially regulated
19. A radioimmunoassay for human interleukin-1α: Measurement of IL-1α produced in vitro by human blood mononuclear cells stimulated with endotoxin
20. Development and use of a radioimmunoassay for human interleukin-1β
21. Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro
22. Detection of tumor necrosis factor soluble receptor p55 (TNFsrp55) in blood samples from healthy and endotoxemic humans
23. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding IL-1 to its type II receptor on human monocytes
24. Production of interleukin-1 receptor antagonist during endotoxemia
25. Antibodies to cachectin/tumor necrosis factor reduce interleukin-1β and interleukin-6 appearance during lethal bacteremia
26. Shedding of tumor necrosis factor receptors by activated neutrophils
27. Production of IL-1 receptor antagonist by human in vitro-derived macrophages
28. Induction of circulating IL-1 and TNF antagonists by IL-2 administration and their effects on IL-2 induced cytokine production in vitro